CVE-2026-52866 | Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0 authorization
A vulnerability marked as problematic has been reported in Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0. The impacted element is an unknown function. This manipulation causes missing authorization.
This vulnerability appears as CVE-2026-52866. The attacker needs to be present on the local network. There is no available exploit.